When was Dysport approved by the FDA?

The U.S. Food and Drug Administration (FDA) approved Dysport for use in adults for the treatment of upper limb spasticity in 2015, and for lower limb spasticity in 2017. In children, those approvals came in 2020 and 2016, respectively. The medication was first approved by the FDA in 2009 to treat wrinkles across the forehead, called glabellar lines, and for involuntary neck muscle spasms, known as cervical dystonia.